(1COV) Covestro - Ratings and Ratios
Polyurethanes, Polycarbonates, Polyols, Elastomers, Specialty Films
1COV EPS (Earnings per Share)
1COV Revenue
Description: 1COV Covestro
Covestro AG is a leading global supplier of high-tech polymer materials and application solutions, operating through two main segments: Performance Materials and Solutions & Specialties. The company develops and produces a wide range of high-performance materials, including polyurethanes, polycarbonates, and base chemicals, which are used in various industries such as construction, automotive, and electronics.
The Performance Materials segment caters to industries like furniture and wood processing, construction, and automotive, while the Solutions & Specialties segment serves industries like automotive, electrical, electronics, and healthcare. Covestros products are used in a variety of applications, including insulation, mattresses, car seats, solar panel frames, and electric vehicle batteries. With a global presence, the company operates in multiple regions, including Europe, the Americas, and Asia.
To further analyze Covestros performance, some key performance indicators (KPIs) can be considered. The companys return on equity (RoE) is currently negative, indicating a loss. However, the forward price-to-earnings (P/E) ratio is 36.23, suggesting that investors expect the company to recover. Additionally, Covestros market capitalization is approximately 11.46 billion EUR, indicating a significant market presence. The companys dividend yield and payout ratio are also important metrics to consider, as they can indicate the sustainability of the dividend and the companys ability to return value to shareholders.
From a trading perspective, Covestros stock price is currently around 60.40 EUR, with a relatively stable short-term trend indicated by the SMA20 and SMA50. The stocks 52-week high and low are 60.84 EUR and 52.62 EUR, respectively, suggesting a relatively stable price range. To further assess the stocks potential, metrics such as trading volume, bid-ask spread, and order book depth can be analyzed to gauge market liquidity and sentiment.
1COV Stock Overview
| Market Cap in USD | 13,340m |
| Sub-Industry | Specialty Chemicals |
| IPO / Inception |
1COV Stock Ratings
| Growth Rating | 55.7% |
| Fundamental | 40.8% |
| Dividend Rating | 16.0% |
| Return 12m vs S&P 500 | -7.62% |
| Analyst Rating | - |
1COV Dividends
Currently no dividends paid1COV Growth Ratios
| Growth Correlation 3m | 15.7% |
| Growth Correlation 12m | 86.1% |
| Growth Correlation 5y | 49.5% |
| CAGR 5y | 10.50% |
| CAGR/Max DD 5y | 0.21 |
| Sharpe Ratio 12m | 0.42 |
| Alpha | 5.12 |
| Beta | -0.032 |
| Volatility | 7.35% |
| Current Volume | 29.5k |
| Average Volume 20d | 21.2k |
| Stop Loss | 58 (-3.1%) |
| Signal | -2.23 |
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (-378.0m TTM) > 0 and > 6% of Revenue (6% = 830.1m TTM) |
| FCFTA 0.01 (>2.0%) and ΔFCFTA 0.48pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 11.52% (prev 18.17%; Δ -6.65pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.06 (>3.0%) and CFO 758.0m > Net Income -378.0m (YES >=105%, WARN >=100%) |
| Net Debt (-489.0m) to EBITDA (904.0m) ratio: -0.54 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.39 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (188.7m) change vs 12m ago 0.0% (target <= -2.0% for YES) |
| Gross Margin 14.09% (prev 15.82%; Δ -1.73pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 101.8% (prev 101.0%; Δ 0.78pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -0.59 (EBITDA TTM 904.0m / Interest Expense TTM 142.0m) >= 6 (WARN >= 3) |
Altman Z'' 1.61
| (A) 0.12 = (Total Current Assets 5.64b - Total Current Liabilities 4.04b) / Total Assets 13.21b |
| (B) 0.15 = Retained Earnings (Balance) 2.03b / Total Assets 13.21b |
| (C) -0.01 = EBIT TTM -84.0m / Avg Total Assets 13.59b |
| (D) 0.34 = Book Value of Equity 2.41b / Total Liabilities 7.04b |
| Total Rating: 1.61 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 40.82
| 1. Piotroski 4.50pt = -0.50 |
| 2. FCF Yield 0.58% = 0.29 |
| 3. FCF Margin 0.64% = 0.16 |
| 4. Debt/Equity 0.74 = 2.24 |
| 5. Debt/Ebitda 5.02 = -2.50 |
| 6. ROIC - WACC data missing |
| 7. RoE -5.85% = -0.97 |
| 8. Rev. Trend -75.64% = -3.78 |
| 9. Rev. CAGR -10.74% = -1.79 |
| 10. EPS Trend 7.11% = 0.18 |
| 11. EPS CAGR -102.3% = -2.50 |
What is the price of 1COV shares?
Over the past week, the price has changed by -0.63%, over one month by -0.86%, over three months by -0.27% and over the past year by +8.05%.
Is Covestro a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of 1COV is around 58.04 EUR . This means that 1COV is currently overvalued and has a potential downside of -3.04%.
Is 1COV a buy, sell or hold?
What are the forecasts/targets for the 1COV price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 61.3 | 2.4% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 63.2 | 5.6% |
1COV Fundamental Data Overview
Market Cap EUR = 11.45b (11.45b EUR * 1.0 EUR.EUR)
CCE Cash And Equivalents = 566.0m EUR (Cash And Short Term Investments, last quarter)
P/E Forward = 36.2319
P/S = 0.8281
P/B = 1.8619
P/EG = 0.5107
Beta = 1.061
Revenue TTM = 13.84b EUR
EBIT TTM = -84.0m EUR
EBITDA TTM = 904.0m EUR
Long Term Debt = 3.00b EUR (from nonCurrentLiabilitiesTotal, last quarter)
Short Term Debt = 1.55b EUR (from shortTermDebt, last quarter)
Debt = 4.54b EUR (Calculated: Short Term 1.55b + Long Term 3.00b)
Net Debt = -489.0m EUR (from netDebt column, last quarter)
Enterprise Value = 15.43b EUR (11.45b + Debt 4.54b - CCE 566.0m)
Interest Coverage Ratio = -0.59 (Ebit TTM -84.0m / Interest Expense TTM 142.0m)
FCF Yield = 0.58% (FCF TTM 89.0m / Enterprise Value 15.43b)
FCF Margin = 0.64% (FCF TTM 89.0m / Revenue TTM 13.84b)
Net Margin = -2.73% (Net Income TTM -378.0m / Revenue TTM 13.84b)
Gross Margin = 14.09% ((Revenue TTM 13.84b - Cost of Revenue TTM 11.88b) / Revenue TTM)
Tobins Q-Ratio = 6.39 (Enterprise Value 15.43b / Book Value Of Equity 2.41b)
Interest Expense / Debt = 0.75% (Interest Expense 34.0m / Debt 4.54b)
Taxrate = 636.4% (set to none) (from quarterly Income Tax Expense: 70.0m / 11.0m)
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = 1.39 (Total Current Assets 5.64b / Total Current Liabilities 4.04b)
Debt / Equity = 0.74 (Debt 4.54b / last Quarter total Stockholder Equity 6.15b)
Debt / EBITDA = 5.02 (Net Debt -489.0m / EBITDA 904.0m)
Debt / FCF = 51.03 (Debt 4.54b / FCF TTM 89.0m)
Total Stockholder Equity = 6.47b (last 4 quarters mean)
RoA = -2.86% (Net Income -378.0m, Total Assets 13.21b )
RoE = -5.85% (Net Income TTM -378.0m / Total Stockholder Equity 6.47b)
RoCE = -0.89% (Ebit -84.0m / (Equity 6.47b + L.T.Debt 3.00b))
RoIC = unknown (NOPAT none, Invested Capital 7.06b, Ebit -84.0m)
WACC = unknown (E(11.45b)/V(15.99b) * Re(5.90%)) + (D(4.54b)/V(15.99b) * Rd(0.75%) * (1-Tc(none)))
Shares Correlation 5-Years: -89.40 | Cagr: -0.58%
Discount Rate = 5.90% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 70.46% ; FCFE base≈64.2m ; Y1≈42.2m ; Y5≈19.3m
Fair Price DCF = 2.01 (DCF Value 378.9m / Shares Outstanding 188.7m; 5y FCF grow -40.0% → 3.0% )
Revenue Correlation: -75.64 | Revenue CAGR: -10.74%
Rev Growth-of-Growth: 10.55
EPS Correlation: 7.11 | EPS CAGR: -102.3%
EPS Growth-of-Growth: 33.95